RIA Advisory Group’s Idexx Laboratories IDXX Stock Holding History

RIA Advisory Group’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$225K	Buy	427 +1	+0.2%	+$561	0.05%	137
2026 Q1	$239K	Buy	426 +21	+5%	+$13.5K	0.06%	124
2025 Q4	$274K	Sell	405 -1	-0.2%	-$681	0.07%	117
2025 Q3	$259K	Buy	406 +1	+0.2%	+$607	0.07%	125
2025 Q2	$217K	Buy	+405	New	+$194K	0.06%	121
2024 Q4	–	Sell	-442	Closed	-$223K	–	142
2024 Q3	$223K	Buy	+442	New	+$215K	0.08%	118
2024 Q1	$270K	Sell	500 -36,132	-99%	-$19.7M	0.11%	114
2023 Q4	$5.99M	Buy	36,632 +35,841	+4,531%	+$16.8M	2.5%	5
2023 Q3	$346K	Buy	791 +225	+40%	+$112K	0.15%	75
2023 Q2	$284K	Sell	566 -6	-1%	-$2.88K	0.12%	85
2023 Q1	$286K	Buy	572 +22	+4%	+$10.5K	0.13%	86
2022 Q4	$219K	Buy	+550	New	+$213K	0.13%	80

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

RIA Advisory Group's IDXX Position: Q2 2026 in Review

RIA Advisory Group increased its Idexx Laboratories (IDXX) stake by 0.23% in Q2 2026, buying an estimated $561 and bringing the position to 427 shares worth $225K. The position accounts for 0.05% of the portfolio, ranked #137.

RIA Advisory Group first reported a position in IDXX in Q4 2022 and has held it in 12 quarters since. The position peaked at $5.99M in Q4 2023. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

RIA Advisory Group held 427 shares of Idexx Laboratories worth $225K as of Q2 2026.
RIA Advisory Group bought 1 Idexx Laboratories share in Q2 2026, an estimated $561.
Idexx Laboratories made up 0.05% of RIA Advisory Group's portfolio in Q2 2026, its #137 holding.
RIA Advisory Group first reported a position in Idexx Laboratories in Q4 2022 and has held it in 12 quarters since.
RIA Advisory Group's Idexx Laboratories position peaked at $5.99M in Q4 2023.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on RIA Advisory Group's 13F filing for Q2 2026, filed 23 Jul 2026.